The outcome of medical nutrition therapy on glycemic control among type 2 diabetic patients.

Autor: Abdelsalam SE; Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt., Ismaail MAR; Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt., Sultan EA; Department of Endocrinology, National Institute of Nutrition, El Sayeda Zeinab, Egypt., Elsherif OE; Cairo University Hospitals, Cairo University, Cairo, Egypt., Salama HM; Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt., Hassan SI; Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismaïlia, Egypt.
Jazyk: angličtina
Zdroj: The Pan African medical journal [Pan Afr Med J] 2023 Jun 15; Vol. 45, pp. 85. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).
DOI: 10.11604/pamj.2023.45.85.35520
Abstrakt: Introduction: the global prevalence of type 2 diabetes in adults is estimated to be 6.4%. The current prevalence of type 2 diabetes in Egyptians aged 20 to 79 is approximately 15.6%. The objective of medical nutrition therapy (MNT) is to optimize the management of the "ABC" for diabetes control, glycated hemoglobin, blood pressure, and cholesterol. Our study aimed to assess the effect of MNT on glycemic control in patients with type 2 diabetes attending the family practice clinic.
Methods: a quasi-experimental intervention trial was conducted with 40 diabetic patients seeking medical service in the Suez Canal University Hospital family practice clinic. The participants were over 20 years old and had uncontrolled type 2 diabetes. Patients were surveyed using El-Gilany questionnaire to evaluate the socio-demographic traits, physical examination data, and laboratory investigations at baseline and after 12 weeks.
Results: medical nutrition therapy (MNT) significantly reduced glycated hemoglobin level (p<0.001); the median level of glycated hemoglobin was 10% with a minimum level of 7.5% vs. a maximum of 14% in the pre-intervention phase. In comparison, the median glycated hemoglobin level was 9.5%, with a minimum level of 5.6% vs. a maximum of 13.5% in the post-intervention phase. In addition, there was a significant improvement in blood pressure, weight, body mass index, fasting plasma glucose, and lipid profile. Conclusion: there is evidence that MNT is a crucial component of type 2 diabetes therapy.
Competing Interests: The authors declare no competing interests.
(Copyright: Shimaa Elsayed Abdelsalam et al.)
Databáze: MEDLINE
Externí odkaz: